Evidence map›Paper›PMID 11739727›Full record

ArticleMolecular and cellular biology2002

Stat6 and IRS-2 cooperate in interleukin 4 (IL-4)-induced proliferation and differentiation but are dispensable for IL-4-dependent rescue from apoptosis.

Andrea L Wurster, Dominic J Withers, Tohru Uchida, Morris F White, Michael J Grusby

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 87 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Andrea L WursterDepartment of Immunology and Infectious Diseases, Harvard School of Public Health. Harvard Medical School, Boston, Massachusetts 02115, USA.
Dominic J Withers
Tohru Uchida
Morris F White
Michael J Grusby
Joslin Diabetes Center · USHarvard University · US

Funding

REGULATION OF THE DIFFERENTIATION AND FUNCTION OF TH2 CER01AI040171 · NIAID · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI GRUSBY, MICHAEL J · 1997 to 2006
$1.9M
ALTERING INTERLEUKIN 4 FUNCTION IN VIVOR21AI040171 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI GRUSBY, MICHAEL J · 1996 to 1996
–
NIAID NIH HHS AI40171NIAID NIH HHS R01 AI040171
6 · The paper itself

Abstract

Stat6 and IRS-2 are two important signaling proteins that associate with the cytoplasmic tail of the interleukin 4 (IL-4) receptor. Data from numerous in vitro experiments have led to a model for IL-4 signal transduction in which the Stat6 signaling pathway is responsible for the IL-4 induced changes in gene expression and differentiation events, while the IRS-2 signaling pathway provides mitogenic and antiapoptotic signals. In order to determine the relative contributions of these signaling molecules in primary lymphocytes, we have examined IL-4 responses in T cells from mice deficient for either Stat6 or IRS-2 as well as from mice doubly deficient for both genes. Both IRS-2 and, especially, Stat6 are shown to be critically involved in IL-4-induced proliferation of T cells, presumably through the cooperative regulation of the Cdk inhibitor p27kip1. Like Stat6-deficient Th cells, IRS-2-deficient cells are also compromised in their ability to secrete Th2 cytokines, revealing a previously unrecognized role for IRS-2 in Th2 cell development. Although Stat6 and/or IRS-2 expression is required for IL-4-induced proliferative and differentiative responses, both signaling proteins are dispensable for the antiapoptotic effect of IL-4. However, treatment of lymphocytes with a protein tyrosine phosphatase inhibitor is able to block the antiapoptotic effect of IL-4 specifically in Stat6- or IRS-2-deficient cells and not in wild-type cells. Our results suggest that Stat6 and IRS-2 cooperate in promoting both IL-4-induced proliferative and differentiating responses, while an additional signaling mediator that depends on protein tyrosine phosphatase activity contributes to the antiapoptotic activities of IL-4 in primary T cells.

Indexed as

AnimalsApoptosisCell Cycle ProteinsCell DifferentiationCell DivisionCells, CulturedCell SeparationCyclin-Dependent Kinase Inhibitor p27Enzyme InhibitorsFlow CytometryInsulin Receptor Substrate ProteinsInterleukin-4Intracellular Signaling Peptides and ProteinsMiceMice, KnockoutPhosphatidylinositol 3-KinasesCdkn1b protein, mouseCell Cycle ProteinsCyclin-Dependent Kinase Inhibitor p27Enzyme InhibitorsInsulin Receptor Substrate ProteinsInterleukin-4Intracellular Signaling Peptides and ProteinsIrs2 protein, mousePhosphatidylinositol 3-KinasesPhosphoproteinsStat6 protein, mouseSTAT6 Transcription FactorTrans-ActivatorsTumor Suppressor Proteins

Identifiers

PMID11739727
PMCPMC134231
OpenAlexW2145611033

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.